Bloomberg reports that Johnson & Johnson is looking to buy surgical robotics firm Auris Health Inc.
J&J is seeking to purchase Auris at a premium to the valuation from its latest funding round that valued the company at $2 billion, Bloomberg reported. So far, a final deal has not been reached and discussions are not guaranteed to lead to a sale of Auris.